Since its establishment in 2000, InnoMedica has evolved from a private investment company with focus on healthcare to an operative venture. The InnoMedica-team already assisted other successful ventures. The vast experience in the Life Science sector combined with broad expertise in capital markets build the optimal foundation for the successful development of a diversified product pipeline.
The main share holders of InnoMedica are the families Halbherr, Yamazaki, Früh und Bron. Together they own 51% of shares. Five successful financing rounds gained InnoMedica a broad shareholder community of more than 450 private investors, that allow the company to realize the project.
Become a shareholder of InnoMedica and participate in the capital increase 2018 with subscription period until May 31st, 2018. Meet the InnoMedica team at one of the information events for interested investors or read more about InnoMedica in the investor documents.
INFORMATION FOR INVESTORS
InnoMedica offers the registration of shareholders interested in purchasing shares and both mediates and conducts share buy-backs. The trading of stock will be suspended depending on the progress regarding on-going research and development projects in order to preclude insider trading. If you are interested in more detailed information regarding our project or in purchasing shares of InnoMedica please use the contact form below: